Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Mindrinos is active.

Publication


Featured researches published by Michael Mindrinos.


Nature | 2005

A network-based analysis of systemic inflammation in humans

Steve E. Calvano; Wenzhong Xiao; Daniel R. Richards; Ramon M. Felciano; Henry V. Baker; Raymond J. Cho; Richard O. Chen; Bernard H. Brownstein; J. Perren Cobb; S. Kevin Tschoeke; Carol Miller-Graziano; Lyle L. Moldawer; Michael Mindrinos; Ronald W. Davis; Ronald G. Tompkins; Stephen F. Lowry

Oligonucleotide and complementary DNA microarrays are being used to subclassify histologically similar tumours, monitor disease progress, and individualize treatment regimens. However, extracting new biological insight from high-throughput genomic studies of human diseases is a challenge, limited by difficulties in recognizing and evaluating relevant biological processes from huge quantities of experimental data. Here we present a structured network knowledge-base approach to analyse genome-wide transcriptional responses in the context of known functional interrelationships among proteins, small molecules and phenotypes. This approach was used to analyse changes in blood leukocyte gene expression patterns in human subjects receiving an inflammatory stimulus (bacterial endotoxin). We explore the known genome-wide interaction network to identify significant functional modules perturbed in response to this stimulus. Our analysis reveals that the human blood leukocyte response to acute systemic inflammation includes the transient dysregulation of leukocyte bioenergetics and modulation of translational machinery. These findings provide insight into the regulation of global leukocyte activities as they relate to innate immune system tolerance and increased susceptibility to infection in humans.


Cell | 1994

The A. thaliana disease resistance gene RPS2 encodes a protein containing a nucleotide-binding site and leucine-rich repeats

Michael Mindrinos; Fumiaki Katagiri; Guo-Liang Yu; Frederick M. Ausubel

In plants, resistance to a pathogen is frequently correlated with a genetically defined interaction between a plant resistance gene and a corresponding pathogen avirulence gene. A simple model explains these gene-for-gene interactions: avirulence gene products generate signals (ligands), and resistance genes encode cognate receptors. The A. thaliana RPS2 gene confers resistance to the bacterial pathogen P. syringae carrying the avirulence gene avrRpt2. A map-based positional cloning strategy was used to identify RPS2. The identification of RPS2 was verified using a newly developed transient assay for RPS2 function and by genetic complementation in transgenic plants. RPS2 encodes a novel 105 kDa protein containing a leucine zipper, a nucleotide-binding site, and 14 imperfect leucine-rich repeats.


Journal of Experimental Medicine | 2011

A genomic storm in critically injured humans

Wenzhong Xiao; Michael Mindrinos; Junhee Seok; Joseph Cuschieri; Alex G. Cuenca; Hong Gao; Douglas L. Hayden; Laura Hennessy; Ernest E. Moore; Joseph P. Minei; Paul E. Bankey; Jeffrey L. Johnson; Jason L. Sperry; Avery B. Nathens; Timothy R. Billiar; Michael A. West; Bernard H. Brownstein; Philip H. Mason; Henry V. Baker; Celeste C. Finnerty; Marc G. Jeschke; M. Cecilia Lopez; Matthew B. Klein; Richard L. Gamelli; Nicole S. Gibran; Brett D. Arnoldo; Weihong Xu; Yuping Zhang; Steven E. Calvano; Grace P. McDonald-Smith

Critical injury in humans induces a genomic storm with simultaneous changes in expression of innate and adaptive immunity genes.


PLOS ONE | 2012

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines

Ashley A. Powell; AmirAli Talasaz; Haiyu Zhang; Marc A. Coram; Anupama Reddy; Glenn Deng; Melinda L. Telli; Ranjana H. Advani; Robert W. Carlson; Joseph A. Mollick; Shruti Sheth; Allison W. Kurian; James M. Ford; Frank E. Stockdale; Stephen R. Quake; R. Fabian Pease; Michael Mindrinos; Gyan Bhanot; Shanaz H. Dairkee; Ronald W. Davis; Stefanie S. Jeffrey

Background To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may play a key role in cancer dissemination. Uncovering CTC phenotypes offers a potential avenue to inform treatment. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. Here we demonstrate feasibility of performing high dimensional single CTC profiling, providing early insight into CTC heterogeneity and allowing comparisons to breast cancer cell lines widely used for drug discovery. Methodology/Principal Findings We purified CTCs using the MagSweeper, an immunomagnetic enrichment device that isolates live tumor cells from unfractionated blood. CTCs that met stringent criteria for further analysis were obtained from 70% (14/20) of primary and 70% (21/30) of metastatic breast cancer patients; none were captured from patients with non-epithelial cancer (n = 20) or healthy subjects (n = 25). Microfluidic-based single cell transcriptional profiling of 87 cancer-associated and reference genes showed heterogeneity among individual CTCs, separating them into two major subgroups, based on 31 highly expressed genes. In contrast, single cells from seven breast cancer cell lines were tightly clustered together by sample ID and ER status. CTC profiles were distinct from those of cancer cell lines, questioning the suitability of such lines for drug discovery efforts for late stage cancer therapy. Conclusions/Significance For the first time, we directly measured high dimensional gene expression in individual CTCs without the common practice of pooling such cells. Elevated transcript levels of genes associated with metastasis NPTN, S100A4, S100A9, and with epithelial mesenchymal transition: VIM, TGFß1, ZEB2, FOXC1, CXCR4, were striking compared to cell lines. Our findings demonstrate that profiling CTCs on a cell-by-cell basis is possible and may facilitate the application of ‘liquid biopsies’ to better model drug discovery.


The Plant Cell | 1991

Induction of Arabidopsis defense genes by virulent and avirulent Pseudomonas syringae strains and by a cloned avirulence gene.

Xinnian Dong; Michael Mindrinos; Keith Davis; Frederick M. Ausubel

We developed a model system to study the signal transduction pathways leading to the activation of Arabidopsis thaliana genes involved in the defense against pathogen attack. Here we describe the identification and characterization of virulent and avirulent Pseudomonas syringae strains that elicit disease or resistance symptoms when infiltrated into Arabidopsis leaves. The virulent and avirulent strains were characterized by determining growth of the pathogen in Arabidopsis leaves and by measuring accumulation of mRNA corresponding to Arabidopsis phenylalanine ammonia-lyase (PAL), beta-1,3-glucanase (BG), and chalcone synthase (CHS) genes in infected leaves. The virulent strain, P. syringae pv maculicola ES4326, multiplied 10(5)-fold in Arabidopsis leaves and strongly elicited BG1, BG2, and BG3 mRNA accumulation but had only a modest effect on PAL mRNA accumulation. In contrast, the avirulent strain, P. syringae pv tomato MM1065, multiplied less than 10-fold in leaves and had only a minimal effect on BG1, BG2, and BG3 mRNA accumulation, but it induced PAL mRNA accumulation. No accumulation of CHS mRNA was found with either ES4326 or MM1065. We also describe the cloning of a putative avirulence (avr) gene from the avirulent strain MM1065 that caused the virulent strain ES4326 to grow less well in leaves and to strongly elicit PAL but not BG1 and BG3 mRNA accumulation. These results suggest that the Arabidopsis PAL and BG genes may be activated by distinct signal transduction pathways and show that differences in plant gene induction by virulent and avirulent strains can be attributed to a cloned presumptive avr gene.


Proceedings of the National Academy of Sciences of the United States of America | 2009

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

AmirAli Talasaz; Ashley A. Powell; David E. Huber; James G. Berbee; Kyung Ho Roh; Wong Yu; Wenzhong Xiao; Mark M. Davis; R. Fabian Pease; Michael Mindrinos; Stefanie S. Jeffrey; Ronald W. Davis

The enumeration of rare circulating epithelial cells (CEpCs) in the peripheral blood of metastatic cancer patients has shown promise for improved cancer prognosis. Moving beyond enumeration, molecular analysis of CEpCs may provide candidate surrogate endpoints to diagnose, treat, and monitor malignancy directly from the blood samples. Thorough molecular analysis of CEpCs requires the development of new sample preparation methods that yield easily accessible and purified CEpCs for downstream biochemical assays. Here, we describe a new immunomagnetic cell separator, the MagSweeper, which gently enriches target cells and eliminates cells that are not bound to magnetic particles. The isolated cells are easily accessible and can be extracted individually based on their physical characteristics to deplete any cells nonspecifically bound to beads. We have shown that our device can process 9 mL of blood per hour and captures >50% of CEpCs as measured in spiking experiments. We have shown that the separation process does not perturb the gene expression of rare cells. To determine the efficiency of our platform in isolating CEpCs from patients, we have isolated CEpCs from all 47 tubes of 9-mL blood samples collected from 17 women with metastatic breast cancer. In contrast, we could not find any circulating epithelial cells in samples from 5 healthy donors. The isolated CEpCs are all stored individually for further molecular analysis.


Nature Genetics | 1999

Genome-wide mapping with biallelic markers in Arabidopsis thaliana

Raymond J. Cho; Michael Mindrinos; Daniel R. Richards; Ronald J. Sapolsky; Mary Anderson; Eliana Drenkard; Julia Dewdney; T. Lynne Reuber; Melanie Stammers; Nancy A. Federspiel; Athanasios Theologis; Wei-Hsien Yang; Earl Hubbell; Melinda Au; Edward Y. Chung; Deval Lashkari; Bertrand Lemieux; Caroline Dean; Robert J. Lipshutz; Frederick M. Ausubel; Ronald W. Davis; Peter J. Oefner

Single-nucleotide polymorphisms, as well as small insertions and deletions (here referred to collectively as simple nucleotide polymorphisms, or SNPs), comprise the largest set of sequence variants in most organisms. Positional cloning based on SNPs may accelerate the identification of human disease traits and a range of biologically informative mutations. The recent application of high-density oligonucleotide arrays to allele identification has made it feasible to genotype thousands of biallelic SNPs in a single experiment. It has yet to be established, however, whether SNP detection using oligonucleotide arrays can be used to accelerate the mapping of traits in diploid genomes. The cruciferous weed Arabidopsis thaliana is an attractive model system for the construction and use of biallelic SNP maps. Although important biological processes ranging from fertilization and cell fate determination to disease resistance have been modelled in A. thaliana, identifying mutations in this organism has been impeded by the lack of a high-density genetic map consisting of easily genotyped DNA markers. We report here the construction of a biallelic genetic map in A. thaliana with a resolution of 3.5 cM and its use in mapping Eds16, a gene involved in the defence response to the fungal pathogen Erysiphe orontii. Mapping of this trait involved the high-throughput generation of meiotic maps of F2 individuals using high-density oligonucleotide probe array-based genotyping. We developed a software package called InterMap and used it to automatically delimit Eds16 to a 7-cM interval on chromosome 1. These results are the first demonstration of biallelic mapping in diploid genomes and establish means for generalizing SNP-based maps to virtually any genetic organism.


PLOS Biology | 2004

A Transcriptional Profile of Aging in the Human Kidney

Graham Rodwell; Rebecca Sonu; Jacob M. Zahn; James Lund; Julie Wilhelmy; Lingli Wang; Wenzhong Xiao; Michael Mindrinos; Emily Crane; Eran Segal; Bryan D. Myers; James D. Brooks; Ronald W. Davis; John P. Higgins; Art B. Owen; Stuart K. Kim

In this study, we found 985 genes that change expression in the cortex and the medulla of the kidney with age. Some of the genes whose transcripts increase in abundance with age are known to be specifically expressed in immune cells, suggesting that immune surveillance or inflammation increases with age. The age-regulated genes show a similar aging profile in the cortex and the medulla, suggesting a common underlying mechanism for aging. Expression profiles of these age-regulated genes mark not only age, but also the relative health and physiology of the kidney in older individuals. Finally, the set of aging-regulated kidney genes suggests specific mechanisms and pathways that may play a role in kidney degeneration with age.


Nature Methods | 2007

Multiplexed protein detection by proximity ligation for cancer biomarker validation

Simon Fredriksson; William Dixon; Hanlee P. Ji; Albert C. Koong; Michael Mindrinos; Ronald W. Davis

We present a proximity ligation–based multiplexed protein detection procedure in which several selected proteins can be detected via unique nucleic-acid identifiers and subsequently quantified by real-time PCR. The assay requires a 1-μl sample, has low-femtomolar sensitivity as well as five-log linear range and allows for modular multiplexing without cross-reactivity. The procedure can use a single polyclonal antibody batch for each target protein, simplifying affinity-reagent creation for new biomarker candidates.


Molecular & Cellular Proteomics | 2005

Quantitative proteome analysis of human plasma following in vivo lypopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach

Wei Jun Qian; Matthew E. Monroe; Tao Liu; Jon M. Jacobs; Gordon A. Anderson; Yufeng Shen; Ronald J. Moore; David J. Anderson; Rui Zhang; Steve E. Calvano; Stephen F. Lowry; Wenzhong Xiao; Lyle L. Moldawer; Ronald W. Davis; Ronald G. Tompkins; David G. Camp; Richard D. Smith; Henry V. Baker; Paul E. Bankey; Timothy R. Billiar; Bernard H. Brownstein; Irshad H. Chaudry; J. Perren Cobb; Adrian Fay; Robert J. Feezor; Brad Freeman; Richard L. Gamelli; Nicole S. Gibran; Brian G. Harbrecht; Doug Hayden

Identification of novel diagnostic or therapeutic biomarkers from human blood plasma would benefit significantly from quantitative measurements of the proteome constituents over a range of physiological conditions. Herein we describe an initial demonstration of proteome-wide quantitative analysis of human plasma. The approach utilizes postdigestion trypsin-catalyzed 16O/18O peptide labeling, two-dimensional LC-FTICR mass spectrometry, and the accurate mass and time (AMT) tag strategy to identify and quantify peptides/proteins from complex samples. A peptide accurate mass and LC elution time AMT tag data base was initially generated using MS/MS following extensive multidimensional LC separations to provide the basis for subsequent peptide identifications. The AMT tag data base contains >8,000 putative identified peptides, providing 938 confident plasma protein identifications. The quantitative approach was applied without depletion of high abundance proteins for comparative analyses of plasma samples from an individual prior to and 9 h after lipopolysaccharide (LPS) administration. Accurate quantification of changes in protein abundance was demonstrated by both 1:1 labeling of control plasma and the comparison between the plasma samples following LPS administration. A total of 429 distinct plasma proteins were quantified from the comparative analyses, and the protein abundances for 25 proteins, including several known inflammatory response mediators, were observed to change significantly following LPS administration.

Collaboration


Dive into the Michael Mindrinos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernard H. Brownstein

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge